Journal Mobile Options

Vol. 64, No. 4, 2003

Issue release date: May 2003

Select / Unselect all
Review
289

Hormonal Therapy in Postmenopausal Women with Breast Cancer

Campos S.M. · Winer E.P.
Oncology 2003;64:289–299 (DOI:10.1159/000070284)
Clinical Study
300

Weekly Low-Dose Docetaxel in Advanced Hormone-Resistant Prostate Cancer Patients Previously Exposed to Chemotherapy

Petrioli R. · Pozzessere D. · Messinese S. · Sabatino M. · Di Palma T. · Marsili S. · Correale P. · Manganelli A. · Salvestrini F. · Francini G.
Oncology 2003;64:300–305 (DOI:10.1159/000070285)
306

Phase II Study of Irinotecan and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

Ichiki M. · Rikimaru T. · Gohara R. · Koga T. · Kawayama T. · Matunami M. · Oshita Y. · Kamimura T. · Aizawa H.
Oncology 2003;64:306–311 (DOI:10.1159/000070286)
312

A Systemic Hyperthermia Oncologic Working Group Trial

Ifosfamide, Carboplatin, and Etoposide Combined with 41.8°C Whole-Body Hyperthermia for Metastatic Soft Tissue Sarcoma

Westermann A.M. · Wiedemann G.J. · Jager E. · Jager D. · Katschinski D.M. · Knuth A. · Vörde sive Vörding P.Z. · van Dijk J.D.P. · Finet J. · Neumann A. · Longo W. · Bakhshandeh A. · Tiggelaar C.L. · Gillis W. · Bailey H. · Peters S.O. · Robins H.I.
Oncology 2003;64:312–321 (DOI:10.1159/000070287)
322

Primary Lymphoma of Bone – A Retrospective Study

Experience at the Northern Israel Oncology Center (1979–2000)

Stein M.E. · Kuten A. · Gez E. · Rosenblatt K.E. · Drumea K. · Ben-Shachar M. · Zidan J. · Haim N. · Epelbaum R.
Oncology 2003;64:322–327 (DOI:10.1159/000070288)
328

Biochemotherapy for Metastatic Melanoma with Limited Central Nervous System Involvement

Boasberg P.D. · O’Day S.J. · Kristedja T.S. · Martin M. · Wang H. · Deck R. · Shinn K. · Ames P. · Tamar B. · Petrovich Z.
Oncology 2003;64:328–335 (DOI:10.1159/000070289)
336

18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG-PET) for Staging and Follow-Up of Marginal Zone B-Cell Lymphoma

Hoffmann M. · Kletter K. · Becherer A. · Jäger U. · Chott A. · Raderer M.
Oncology 2003;64:336–340 (DOI:10.1159/000070290)
341

Endometrial Cancer and the IGF System: A Case-Control Study in Greece

Petridou E. · Koukoulomatis P. · Alexe D.M. · Voulgaris Z. · Spanos E. · Trichopoulos D.
Oncology 2003;64:341–345 (DOI:10.1159/000070291)
346

Radiation Treatment for Aggressive Fibromatosis: Findings from Observed Patterns of Local Failure

Park H.C. · Pyo H.R. · Shin K.-H. · Suh C.O.
Oncology 2003;64:346–352 (DOI:10.1159/000070292)
353

Subcutaneous Granulocyte-Macrophage Colony-Stimulating Factor in Mucositis Induced by an Adjuvant 5-Fluorouracil plus Leucovorin Regimen

A Phase II Study and Review of the Literature

Rossi A. · Rosati G. · Colarusso D. · Manzione L.
Oncology 2003;64:353–360 (DOI:10.1159/000070293)
361

Clinicopathological Significance of Nup88 Expression in Patients with Colorectal Cancer

Emterling A. · Skoglund J. · Arbman G. · Schneider J. · Evertsson S. · Carstensen J. · Zhang H. · Sun X.-F.
Oncology 2003;64:361–369 (DOI:10.1159/000070294)
370

Ovarian Sertoli-Leydig Cell Tumor, Endometrioid-Like Yolk Sac Tumor, and Y-Chromosomal Material

De Giorgi U. · Turci D. · Crisanti E. · Cantù M.G. · Cappellini A. · Marangolo M.
Oncology 2003;64:370–373 (DOI:10.1159/000070295)
Laboratory/Clinical Translational Research
374

Heterogenous S-100B Protein Expression Patterns in Malignant Melanoma and Association with Serum Protein Levels

Bánfalvi T. · Udvarhelyi N. · Orosz Z. · Gergye M. · Gilde K. · Tímár J.
Oncology 2003;64:374–379 (DOI:10.1159/000070296)
380

Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers

Asada K. · Miyamoto K. · Fukutomi T. · Tsuda H. · Yagi Y. · Wakazono K. · Oishi S. · Fukui H. · Sugimura T. · Ushijima T.
Oncology 2003;64:380–388 (DOI:10.1159/000070297)
389

Prognostic Role of Apoptotic, Bcl-2, c-erbB-2 and p53 Tumor Markers in Salivary Gland Malignancies

Nagler R.M. · Kerner H. · Ben-Eliezer S. · Minkov I. · Ben-Itzhak O.
Oncology 2003;64:389–398 (DOI:10.1159/000070298)
399

Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel

Fujishita T. · Loda M. · Turner R.E. · Gentler M. · Kashii T. · Breathnach O.S. · Johnson B.E.
Oncology 2003;64:399–406 (DOI:10.1159/000070299)
407

Characteristic Cytokine Generation Patterns in Cancer Cells and Infiltrating Lymphocytes in Oral Squamous Cell Carcinomas and the Influence of Chemoradiation Combined with Immunotherapy on These Patterns

Yamamoto T. · Kimura T. · Ueta E. · Tatemoto Y. · Osaki T.
Oncology 2003;64:407–415 (DOI:10.1159/000070300)
416

Expression of Vascular Endothelial Growth Factor D Is Associated with Lymph Node Metastasis in Human Colorectal Carcinoma

Funaki H. · Nishimura G. · Harada S.-i. · Ninomiya I. · Terada I. · Fushida S. · Tani T. · Fujimura T. · Kayahara M. · Shimizu K. · Ohta T. · Miwa K.
Oncology 2003;64:416–422 (DOI:10.1159/000070301)
423

Reduced Expression of the TSP1 Gene and Its Association with Promoter Hypermethylation in Gastric Carcinoma

Oue N. · Matsumura S. · Nakayama H. · Kitadai Y. · Taniyama K. · Matsusaki K. · Yasui W.
Oncology 2003;64:423–429 (DOI:10.1159/000070302)
430

Sensitive Detection of Human Telomerase Reverse Transcriptase mRNA in the Serum of Patients with Hepatocellular Carcinoma

Miura N. · Shiota G. · Nakagawa T. · Maeda Y. · Sano A. · Marumoto A. · Kishimoto Y. · Murawaki Y. · Hasegawa J.
Oncology 2003;64:430–434 (DOI:10.1159/000070303)
435

Apoptotic Index and bcl-2 Expression as Prognostic Factors in Colorectal Carcinoma

Bendardaf R. · Ristamäki R. · Kujari H. · Laine J. · Lamlum H. · Collan Y. · Pyrhönen S.
Oncology 2003;64:435–442 (DOI:10.1159/000070304)
Laboratory Investigation
443

Expression of Cancer/Testis Tumor Associated Antigens in Cervical Squamous Cell Carcinoma

Sarcevic B. · Spagnoli G.C. · Terracciano L. · Schultz-Thater E. · Heberer M. · Gamulin M. · Krajina Z. · Oresic T. · Separovic R. · Juretic A.
Oncology 2003;64:443–449 (DOI:10.1159/000070305)
450

Identification of a Novel Homeobox-Containing Gene, LAGY, Which Is Downregulated in Lung Cancer

Chen Y. · Petersen S. · Pacyna-Gengelbach M. · Pietas A. · Petersen I.
Oncology 2003;64:450–458 (DOI:10.1159/000070306)
459

Brefeldin A Induces Apoptosis and Cell Cycle Blockade in Glioblastoma Cell Lines

Pommepuy I. · Terro F. · Petit B. · Trimoreau F. · Bellet V. · Robert S. · Hugon J. · Labrousse F. · Yardin C.
Oncology 2003;64:459–467 (DOI:10.1159/000070307)
Case Report
468

Peritoneal Carcinoma in a Male Patient

Jermann M. · Vogt P. · Pestalozzi B.C.
Oncology 2003;64:468–472 (DOI:10.1159/000070308)
Letter to the Editor
473

5-Fluorouracil, Folinic Acid and Oxaliplatin Administered via Hepatic Arterial Infusion as Regional Second-Line Therapy for Advanced Colorectal Cancer

Meyer L. · Hildebrandt B. · Riess H.
Oncology 2003;64:473–474 (DOI:10.1159/000070309)
475

Phase II Study of Cisplatin, Epirubicin, and Continuous-Infusion 5-Fluorouracil for Advanced Biliary Tract Cancer

Morizane C. · Okada S. · Okusaka T. · Ueno H. · Saisho T.
Oncology 2003;64:475–476 (DOI:10.1159/000070310)
477

Gemcitabine plus Irinotecan in Breast Cancer Patients Pretreated with Taxanes and Anthracyclines: A Multicenter Phase II Study

Agelaki S. · Karyda E. · Kouroussis C. · Ardavanis A. · Kalbakis K. · Malas K. · Malamos N. · Alexopoulos A. · Tselepatiotis E. · Georgoulias V.
Oncology 2003;64:477–478 (DOI:10.1159/000070312)
479

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

Rossi E. · Perrone F. · Labonia V. · Landi G. · Nuzzo F. · Amabile G. · Gridelli C. · Di Maio M. · D’Aiuto G. · de Matteis A.
Oncology 2003;64:479–480 (DOI:10.1159/000070313)
Further Section
481

Book Reviews

Oncology 2003;64:481–482 (DOI:10.1159/000071298)
Free Access
483

Author Index Vol. 64, 2003

Oncology 2003;64:483–484 (DOI:10.1159/000071299)
Free Access
485

Subject Index Vol. 64, 2003

Oncology 2003;64:485–486 (DOI:10.1159/000071300)
Free Access
487

Contents Vol. 64, 2003

Oncology 2003;64:487–489 (DOI:10.1159/000071301)
Free Access